2019 Pre-Filled Syringes Forum, Boston

Download Program

February 27-28, 2019, Metro Meeting Centers, Boston, MA

With the Pre-Filled Syringes market expected to top $16 billion dollars by 2021, the industry is looking for next generation materials, technologies and production strategies to streamline commercialization and to adapt quickly to a changing regulatory environment. Pharma Ed Resources, an industry leader since 2004 in delivering market-driven research on PFS, is proud to announce its 2019 Pre-Filled Syringes Forum. Pharma Ed brings together top scientists, regulatory experts and innovators to share best practices and the latest research in this field, enabling you to maximize your organization’s leverage in this dynamic and growing market.

Featuring Representation From:

• Biogen
• Genentech
• Allergan
• Bristol-Myers Squibb
• GSK
• Sanofi Genzyme
• Janssen R&D
• Merck
• Shire
• Ompi
• MedImmune
• Ypsomed AG
• PTI
• Datwyler
• Toxikon
• Bosch
• West
• Unchained Labs
• GessNet
• Zeon

Featuring Comprehensive Coverage On:

• Next Generation Materials & Design of Pre-Filled Syringes
• Understanding Regulatory Requirements for PFS and Auto Injectors
• Latest Auto-Injector Designs, including Wearable-Injector Devices, Pen Injectors, Bolus Injectors, and Patch Pumps
• QbD Applications in the Manufacture of Pre-Filled Syringes
• Leachables and Safety Considerations in Pre-Filled Syringes
• Extractables and Leachables – Toxicological Perspectives on ICH M, and other Guidelines for Efficient Product Development
• Improving Drug Stability in Pre-Filled Syringes
• Pre-Filled Syringes vs. Single Dose Cartridges
• Optimizing Aseptic Filling Processes, Including Automated Inspection
• Challenges in the Use of PFS for Biologics